Drug application

K+8 (POTASSIUM CHLORIDE)

Drugs@FDA ANDA 070998 · FUTURE PAK

Key facts

Drug name K+8
Active ingredients POTASSIUM CHLORIDE
Application type ANDA
Application number 070998
Company FUTURE PAK
Dosage forms TABLET, EXTENDED RELEASE, ORAL
Strength 8MEQ
Marketing status Discontinued
Reference listed drug No
Latest submission status date Jan 25, 1993

At a glance

  • 1–9 Submissions
  • 1–9 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications